Cite
HARVARD Citation
Barbour, A. et al. (n.d.). 631PNeoadjuvant therapy for esophageal adenocarcinoma: A propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy. Annals of oncology. p. . [Online].